When Anxiety Attacks | Pastor Steven Furtick
When Anxiety Attacks | Pastor Steven Furtick
By Daniel J. DeNoon
March 22, 2010 — GlaxoSmithKline’s Rotarix rotavirus vaccine contains DNA from an apparently harmless pig virus, the company and the FDA today announced.
The FDA estimates that 1 million U.S. kids have received the Rotarix vaccine.
The contamination was discovered by researchers developing a new technique for detecting viral material. GlaxoSmithKline confirmed that the pig virus, porcine circovirus type 1 or PCV-1, has been in the vaccine since it was developed.
This means that pig virus DNA was in the vaccine throughout clinical trials. No safety issues emerged from these international studies with 90,000 participants or, GlaxoSmithKline says, in post-marketing surveillance covering more than 69 million doses of the vaccine.
Nevertheless, as a precaution the FDA is asking doctors to stop using the two-dose Rotarix vaccine, which it approved in 2008.
“The message is clearly not a message of safety but of caution going forward,” FDA Commissioner Margaret Hamburg, MD, said at a news conference. “We believe the vaccine is both safe and effective and we strongly encourage vaccination against rotavirus. But we want to more deeply understand the finding of this unexpected material in the product, and that is why we are putting a clinical pause on its use.”
A study published in the Journal Annals of Epidemiology has shown that giving the Hepatitis B vaccine to newborn baby boys could triple the risk of developing an autism spectrum disorder compared to boys who were not vaccinated as neonates. The research was conducted at Stony Brook University Medical Centre, NY.
US National Library of Medicine
National Institutes of Health – 2010
Gallagher CM, Goodman MS.
PhD Program in Population Health and Clinical Outcomes Research, Stony Brook University Medical Center, State University of New York at Stony Brook, Stony Brook, New York, USA. firstname.lastname@example.org
Universal hepatitis B vaccination was recommended for U.S. newborns in 1991; however, safety findings are mixed. The association between hepatitis B vaccination of male neonates and parental report of autism diagnosis was determined. This cross-sectional study used weighted probability samples obtained from National Health Interview Survey 1997-2002 data sets. Vaccination status was determined from the vaccination record. Logistic regression was used to estimate the odds for autism diagnosis associated with neonatal hepatitis B vaccination among boys age 3-17 years, born before 1999, adjusted for race, maternal education, and two-parent household. Boys vaccinated as neonates had threefold greater odds for autism diagnosis compared to boys never vaccinated or vaccinated after the first month of life. Non-Hispanic white boys were 64% less likely to have autism diagnosis relative to nonwhite boys. Findings suggest that U.S. male neonates vaccinated with the hepatitis B vaccine prior to 1999 (from vaccination record) had a threefold higher risk for parental report of autism diagnosis compared to boys not vaccinated as neonates during that same time period. Nonwhite boys bore a greater risk.
A study published in the Journal of Inorganic Biochemistry by researchers at the Neural Dynamics Group, Department of Ophthalmology and Visual Sciences at the University of British Columbia determined that Aluminum, a highly neurotoxic metal and the most commonly used vaccine adjuvant may be a significant contributing factor to the rising prevalence of ASD in the Western World. They showed that the correlation between ASD prevalence and the Aluminum adjuvant exposure appears to be the highest at 3-4 months of age. The studies also show that children from countries with the highest ASD appear to have a much higher exposure to Aluminum from vaccines. The study points out that several prominent milestones of brain development coincide with major vaccination periods for infants. These include the onset of synaptogenesis (birth), maximal growth velocity of the hippocampus and the onset of amygdala maturation. Furthermore, major developmental transition in many bio-behavioural symptoms such as sleep, temperature regulation, respiration and brain wave patterns, all of which are regulated by the neuroendocrine network. Many of these aspects of brain function are known to be impaired in autism, such as sleeping and brain wave patterns.
Journal of Inorganic Biochemistry – 14 Aug 2011
Lucija Tomljenovic a,
Christopher A. Shaw a,b
a Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, Canada V5Z 1L8
b Departments of Ophthalmology and Visual Sciences and Experimental Medicine and the Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, 828 W. 10th Ave, Vancouver, BC, Canada V5Z 1L8
Autism spectrum disorders (ASD) are serious multisystem developmental disorders and an urgent global public health concern. Dysfunctional immunity and impaired brain function are core deficits in ASD. Aluminum (Al), the most commonly used vaccine adjuvant, is a demonstrated neurotoxin and a strong immune stimulator. Hence, adjuvant Al has the potential to induce neuroimmune disorders. When assessing adjuvant toxicity in children, two key points ought to be considered:
(i) children should not be viewed as “small adults” as their unique physiology makes them much more vulnerable to toxic insults;
(ii) if exposure to Al from only few vaccines can lead to cognitive impairment and autoimmunity in adults, is it unreasonable to question whether the current pediatric schedules, often containing 18 Al adjuvanted vaccines, are safe for children? By applying Hill’s criteria for establishing causality between exposure and outcome we investigated whether exposure to Al from vaccines could be contributing to the rise in ASD prevalence in the Western world.
Our results show that:
(i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines;
(ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades (Pearson r=0.92, pb0.0001);
and (iii) a significant correlation exists between the amounts of Al administered to preschool children and the current prevalence of ASD in seven Western countries, particularly at 3–4 months of age (Pearson r=0.89–0.94, p=0.0018–0.0248). The application of the Hill’s criteria to these data indicates that the correlation between Al in vaccines and ASD may be causal. Because children represent a fraction of the population most at risk for complications following exposure to Al, a more rigorous evaluation of Al adjuvant safety seems warranted
According to the FDA, vaccines represent a special category of drugs as they are generally given to healthy individuals. Further according to the FDA, “this places significant emphasis on their vaccine safety”. While the FDA does set an upper limit for Aluminum in vaccines at no more that 850/mg/dose, it is important to note that this amount was selected empirically from data showing that Aluminum in such amounts enhanced the antigenicity of the vaccine, rather than from existing safety. Given that the scientific evidence appears to indicate that vaccine safety is not as firmly established as often believed, it would seem ill advised to exclude paediatric vaccinations as a possible cause of adverse long-term neurodevelopment outcomes , including those associated with autism.
VAXXED TV – My brother has autism from vaccines
I’m a pharmacist and I will never vaccinate again
Vaccines caused my daughters autism and epilepsy
My 3 children are unvaccinated
I’m a nurse and I didn’t know
Type 1 diabetes, autoimmunity and vaccines
The one and only Ginger Taylor
Vaccines gave my children autism, tics, allergies and eczema
Vaccines cause ADHD, allergies and anxiety
Vaccines gave my son autism
Testimony by Phil Robertson from Duck Dynasty
1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:
Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.